Literature DB >> 25155423

Molecular markers for thyroid cancer diagnosis, prognosis, and targeted therapy.

Linwah Yip1.   

Abstract

Molecular markers including gene expression profiles, somatic gene alterations, and circulating peripheral markers have augmented diagnostic, prognostic, and therapeutic options for thyroid cancer patients.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  molecular targeted therapy; thyroid; thyroid cancer; thyroid nodule

Mesh：

Substances：

Year:  2014        PMID： 25155423     DOI： 10.1002/jso.23768

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  11 in total

1.  BRAFV600E mutation: a potential predictor of more than a Sistrunk's procedure in patients with thyroglossal duct cyst carcinoma and a normal thyroid gland.

Authors:  Sohail Bakkar; Elisabetta Macerola; Qusai Aljarrah; Agnese Proietti; Gabriele Materazzi; Fulvio Basolo; Paolo Miccoli
Journal:  Updates Surg       Date:  2019-10-04

2.  Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.

Authors:  Meng-Hui Yuan; Long-Xiao Wei; Run-Suo Zhou; Hai-Feng Xu; Jun-Yan Wang; Qian-Rong Bai
Journal:  Oncol Lett       Date:  2017-10-12       Impact factor: 2.967

3.  Differentiated Thyroid Cancer: How Do Current Practice Guidelines Affect Management?

Authors:  Patrick W Owens; Terri P McVeigh; Eoin J Fahey; Marcia Bell; Denis S Quill; Michael J Kerin; Aoife J Lowery
Journal:  Eur Thyroid J       Date:  2018-09-28

4.  Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma.

Authors:  Roberto Ria; Vittorio Simeon; Assunta Melaccio; Giovanna Di Meo; Stefania Trino; Carmela Mazzoccoli; Ilaria Saltarella; Aurelia Lamanuzzi; Annalisa Morano; Angela Gurrado; Alessandro Pasculli; Gaetano Lastilla; Pellegrino Musto; Antonia Reale; Franco Dammacco; Angelo Vacca; Mario Testini
Journal:  Oncotarget       Date:  2016-05-17

5.  Lipase member H is a downstream molecular target of hypoxia inducible factor-1α and promotes papillary thyroid carcinoma cell migration in BCPAP and KTC-1 cell lines.

Authors:  Yuefeng Li; Xiaofen Zhou; Qiongying Zhang; Endong Chen; Yihan Sun; Danrong Ye; Ouchen Wang; Xiaohua Zhang; Jianxin Lyu
Journal:  Cancer Manag Res       Date:  2019-01-22       Impact factor: 3.989

Review 6.  Personalized treatment options for thyroid cancer: current perspectives.

Authors:  Fatemeh Khatami; Bagher Larijani; Shekoufeh Nikfar; Mandana Hasanzad; Kiarad Fendereski; Seyed Mohammad Tavangar
Journal:  Pharmgenomics Pers Med       Date:  2019-09-13

7.  Cell and Molecular Biology of Thyroid Disorders.

Authors:  Daniela Grimm
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

8.  Cell and Molecular Biology of Thyroid Disorders 2.0.

Authors:  Daniela Grimm
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923

9.  Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.

Authors:  Laurent Fradet; Rabia Temmar; Frédéric Couture; Mathieu Belzile; Pierre-Hugues Fortier; Robert Day
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-10-19

Review 10.  Correlations between Molecular Landscape and Sonographic Image of Different Variants of Papillary Thyroid Carcinoma.

Authors:  Andrzej Lewiński; Zbigniew Adamczewski; Arkadiusz Zygmunt; Leszek Markuszewski; Małgorzata Karbownik-Lewińska; Magdalena Stasiak
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.